Racism and psychosis: how discrimination shapes mental health risk

mark-konig-kn68FkEstR8-unsplash

People from racialised communities face higher risks of psychosis, yet racism itself is rarely studied. A new umbrella review shows why discrimination needs to be recognised as a genuine risk factor, not just a background influence.

[read the full story...]

Psychosis stigma in the Middle East: shining a light on hidden struggles

who-s-denilo-EsWXKMyR-e8-unsplash

Shuichi Suetani and Jon Paul Teo consider a new systematic review, which highlights the significant stigma faced by people with psychosis and their families in Middle Eastern communities, and suggests culturally sensitive ways forward.

[read the full story...]

Cannabis, psychosis and the structural realities for ethnic minorities

ty-dennis-XehmCTvbv9I-unsplash

KCL MSc student Geetika Sharma reviews a study that looks at the contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe.

[read the full story...]

City limits: untreated psychosis in the Global South

james-wiseman-IebZAH6kaNw-unsplash

Izah Bowes considers a cross-sectional study exploring urbanicity and rates of untreated psychotic disorders in three diverse settings in the Global South: Trinidad, India and Nigeria.

[read the full story...]

Just how good are antipsychotics at preventing relapse? Bridging the efficacy-effectiveness gap

pills-water

Samei Huda summarises a new network meta-analysis in the Lancet Psychiatry on the efficacy and effectiveness of antipsychotics for schizophrenia in research settings, such as randomised controlled trials, versus real-world and clinical settings.

[read the full story...]